Literature DB >> 17763118

Mortality among persons with schizophrenia in Sweden: an epidemiological study.

Björn Milesson Fors1, Dag Isacson, Kerstin Bingefors, Birgitta Widerlöv.   

Abstract

The objective of the study was to analyse 10-year mortality among persons with schizophrenia from an epidemiological perspective. This cohort study included all persons with schizophrenia (n=255) living in the northern catchment area in Uppsala in 1991, and 1275 subjects from the national population register matched for sex, age and living area. The prevalence of schizophrenia was 0.37% and the mortality rate for individuals with schizophrenia was higher than for referents: 23.0% vs. 11.2%. The higher mortality among those with schizophrenia was mainly the result of unnatural causes and cardiovascular disease, especially in men. Excess mortality from cardiovascular disease was more pronounced in middle age, irrespective of gender. Multivariate analysis revealed higher mortality among individuals with schizophrenia living in the city than among those living in less urbanized areas. People with schizophrenia die more often than those without schizophrenia from unnatural causes or circulatory diseases. Individuals with schizophrenia die sooner from circulatory diseases than those without schizophrenia. Having schizophrenia and living in the city also results in higher mortality than having schizophrenia and living in other areas. The risk of early death from circulatory disease needs to be studied in more detail to reveal the potential respective contributions of intrinsic patient vulnerability, lifestyle factors and side-effects from psychotropic drugs.

Entities:  

Mesh:

Year:  2007        PMID: 17763118     DOI: 10.1080/08039480701414932

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  13 in total

1.  Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.

Authors:  Christoph U Correll; Marco Solmi; Nicola Veronese; Beatrice Bortolato; Stella Rosson; Paolo Santonastaso; Nita Thapa-Chhetri; Michele Fornaro; Davide Gallicchio; Enrico Collantoni; Giorgio Pigato; Angela Favaro; Francesco Monaco; Cristiano Kohler; Davy Vancampfort; Philip B Ward; Fiona Gaughran; André F Carvalho; Brendon Stubbs
Journal:  World Psychiatry       Date:  2017-06       Impact factor: 49.548

2.  Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia.

Authors:  Nancy E Morden; Zongshan Lai; David E Goodrich; Todd MacKenzie; John F McCarthy; Karen Austin; Deborah E Welsh; Stephen Bartels; Amy M Kilbourne
Journal:  Gen Hosp Psychiatry       Date:  2012-04-18       Impact factor: 3.238

3.  Psychiatric symptoms and mortality in older adults with major psychiatric disorders: results from a multicenter study.

Authors:  Margaux Chene; Marina Sánchez-Rico; Carlos Blanco; Rachel Pascal De Raykeer; Cécile Hanon; Pierre Vandel; Frédéric Limosin; Nicolas Hoertel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-06-20       Impact factor: 5.270

4.  Five-year mortality of Finnish schizophrenia patients in the era of deinstitutionalization.

Authors:  Helena Rantanen; Anna-Maija Koivisto; Raimo K R Salokangas; Mika Helminen; Hannu Oja; Sami Pirkola; Kristian Wahlbeck; Matti Joukamaa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-28       Impact factor: 4.328

5.  Impact of oral antipsychotic medication adherence on healthcare resource utilization among schizophrenia patients with Medicare coverage.

Authors:  Steve Offord; Jay Lin; Bruce Wong; Dario Mirski; Ross A Baker
Journal:  Community Ment Health J       Date:  2013-08-10

6.  Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions.

Authors:  Dieter Schoepf; Hardeep Uppal; Rahul Potluri; Reinhard Heun
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-08-13       Impact factor: 5.270

Review 7.  Mortality in schizophrenia: a measurable clinical endpoint.

Authors:  Chris J Bushe; Mark Taylor; Jari Haukka
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153

8.  Early death in those previously hospitalised for mental healthcare in Scotland: a nationwide cohort study, 1986-2010.

Authors:  Omotomilola Ajetunmobi; Mark Taylor; Diane Stockton; Rachael Wood
Journal:  BMJ Open       Date:  2013-07-30       Impact factor: 2.692

9.  Mortality of young offenders: a national register-based follow-up study of 15- to 19-year-old Finnish delinquents referred for forensic psychiatric examination between 1980 and 2010.

Authors:  Nina Lindberg; Jouko Miettunen; Anni Heiskala; Riittakerttu Kaltiala-Heino
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2017-08-08       Impact factor: 3.033

Review 10.  An evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature review.

Authors:  Jason C Simeone; Alexandra J Ward; Philip Rotella; Jenna Collins; Ricarda Windisch
Journal:  BMC Psychiatry       Date:  2015-08-12       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.